A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus
about
Identification of cellular genes targeted by KSHV-encoded microRNAsHuman herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cellsKaposi's sarcoma-associated herpesvirus vCyclin open reading frame contains an internal ribosome entry siteKaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cellsLatency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virusRapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signalingThe viral etiology of AIDS-associated malignanciesUse of a multi-virus array for the study of human viral and retroviral pathogens: gene expression studies and ChIP-chip analysisKaposi's Sarcoma Herpesvirus Genome PersistenceActivation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes VirusNext-Generation Sequencing in the Understanding of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) BiologyKSHV Genome Replication and MaintenanceKSHV: pathways to tumorigenesis and persistent infectionInhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomersViral Inhibition of PRR-Mediated Innate Immune Response: Learning from KSHV Evasion StrategiesMolecular virology of Kaposi's sarcoma-associated herpesvirusKaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasionKSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANALANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complexSurface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus.Host transcript accumulation during lytic KSHV infection reveals several classes of host responsesPre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.Molecular biology of KSHV in relation to AIDS-associated oncogenesis.The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes.Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter.Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency.Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice.An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrateChromatin organization of gammaherpesvirus latent genomes.Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathwayKaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoterKSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin.BALB/c mice immunized with a combination of virus-like particles incorporating Kaposi sarcoma-associated herpesvirus (KSHV) envelope glycoproteins gpK8.1, gB, and gH/gL induced comparable serum neutralizing antibody activity to UV-inactivated KSHV.Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcomaKaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell lineMurine gammaherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency.Analysis of gene expression in a human cell line stably transduced with herpesvirus saimiri.The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes.
P2860
Q21131610-79514739-FF1A-4DF5-A8C5-7F76D732747BQ24527215-2B902F90-B3CC-4A90-968B-5FBEC5F10157Q24529088-7AFBE2B9-B75B-43E9-AE12-DF0913AFCBE4Q24555724-92E2A9FD-40D0-49AF-9327-DDC14E822066Q24670086-EA8DBCC5-03E7-4D79-913C-DDF5BB5C085CQ24673299-277AC1A7-FF81-415F-86AD-321A5E63C255Q24685892-7D903978-B950-45D9-89C0-36C39113E815Q24799552-0FDAA61E-1493-4B82-ABBA-D3A292223605Q26738483-839AE625-D9A6-4CBD-803C-68FA402007EBQ26743368-E56BA4AE-3E6E-4979-B273-CA875F96C489Q26752599-319EEEC2-CDE4-4E12-A0D8-8FD5B3861417Q26766437-8EE62924-CFF0-495C-B437-9C04EAD6A42BQ27026000-2EE0CA75-BEFB-4601-A257-B3C6E75BE81EQ27486093-E3B0ADEF-1596-447A-8B54-C8E329F0EFB8Q28079936-B7B8CF81-3F3A-4F73-9753-C0C00E200464Q28363323-2C1127F7-5C31-4CF0-AC3D-8037EEE578ACQ28472867-8888DDB4-E41A-4BB7-967D-9A2AE42AE843Q28474913-8698720E-BFED-4DB7-BEC6-F201C9C90D45Q28540872-08B8C266-2FFB-4B69-8593-EEE9511ABCFEQ30311122-1A646FA6-BFAB-41DF-8050-1D1522B2180CQ33295395-3C84CB3B-B61B-4D15-BC86-E806D33AD375Q33432690-04944282-ED2B-4B3F-9A49-28C04BF8FD8FQ33545232-AE6057AB-484E-4904-B551-208ED5AC9A32Q33560572-13CC6003-CCBE-4A90-8C11-1C9A264E624CQ33598569-F79EB92B-59DB-4B63-8D40-7CB6183709AEQ33641552-92EC5728-0A12-43B8-A089-AC087F53CD78Q33648926-1142F7F6-0FE1-4715-B550-EBF000D4F462Q33653581-E464BA0A-F8D3-4F4C-8BCD-79A52DD3A7EBQ33717717-077FA932-9EB5-4206-BC1C-2532D2C488FBQ33729584-9D122E1E-9D8A-4121-B38D-1FF6C84E5170Q33737793-ACF7ADCC-0CC9-4B33-92C8-BFD18130903DQ33748042-F19677C3-1CD9-4D5C-911B-A61D122EE094Q33761091-6CD525CC-A76D-403E-844B-2CFBC893CF7EQ33781363-088AD368-BE42-4C5C-98DD-71847C628FD3Q33798426-6DA3479D-CA49-41BE-BE93-456ECD1E12E4Q33801927-13CFDA93-A168-47AB-9413-F4B6B2C55355Q33807199-58CBCB27-7B73-4FC2-82CB-C49C2D94843AQ33808932-8430A07A-ADD0-4717-BC12-53911A298E81Q33809466-95B4C5E6-46CB-458D-A9F7-24BD088BAB01Q33814440-D47507F6-47C3-4BD5-8A58-EE65F015F129
P2860
A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus
@ast
A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus
@en
type
label
A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus
@ast
A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus
@en
prefLabel
A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus
@ast
A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus
@en
P2093
P2860
P1433
P1476
A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus
@en
P2093
P2860
P304
P50
P577
1998-10-01T00:00:00Z